By Dr Ashraf Zaman

Journal articles

Yuile A; Satgunaseelan L; Alexander KL; Thavaneswaran S; Sim H-W; Zaman A; Powell J; Meng A; Escher C; Wei JQ; Wei G; Lee M; Buckland ME; Kong BY; Kastelan M; Wong M; Wilson I; Bayly A; Varikatt W; Lwin Z; Rodriguez M; Soh HC; Gill A; Zakarya R; Back MF; Pavlakis N; Chan DL; Lee A; Wheeler HR; Hudson AL, 2025, 'PATH-18. Investigating the role of CDKN2A loss in IDH-mutant gliomas: biological insights beyond tumour grading', Neuro-Oncology, 27, pp. v243 - v244, http://dx.doi.org/10.1093/neuonc/noaf201.0970

Southi N; Sim H-W; Grady J; Satgunaseelan L; Huang M; Kansara M; Yuile A; Zaman A; Lin F; Wheeler H; Hudson A; Ballinger ML; Thomas DM; Thavaneswaran S, 2025, 'PATH-52. Understanding the prevalence of MTAP and CDKN2A/B deletion in gliomas by next generation sequencing', Neuro-Oncology, 27, pp. v252 - v252, http://dx.doi.org/10.1093/neuonc/noaf201.1004

Dsouza R; Skarne N; Martins P; Offenhauser C; Mulay O; Harris L; Holton E; Zaman A; Akgul S; Smith F; Alexander H; Lwin Z; Inglis P-L; Jeffree R; Powell J; Khanna R; Boyd A; Ngyuen Q; Day B, 2025, 'STEM-10. TARGETING EPH FAMILY OF RECEPTORS: ADVANCED PRECISION THERAPY FOR GBM', Neuro-Oncology, 27, pp. v79 - v80, http://dx.doi.org/10.1093/neuonc/noaf201.0318

Brenner DA; Dadario NB; Zaman A; Valdivia DJ; Pandya M; Yeung J; Sughrue M; Teo C, 2025, 'Surgical outcomes in high-grade adult type diffuse gliomas (ATDG) with a previous diagnosis of anaplastic astrocytoma without adjuvant therapy', Clinical Neurology and Neurosurgery, 253, pp. 108879, http://dx.doi.org/10.1016/j.clineuro.2025.108879

Zaman A; Muskovic W; Holton E; Pandya M; Zekanovic R; Chin V; Lam E; Moutinho C; Yeung J; Teo C; Sughrue M; Powell J, 2024, 'STEM-01. SHARED ASTROCYTE-LIKE GLIOMA STEM CELLS DRIVE HETEROGENEITY AND IMMUNE DYNAMICS IN ADULT-TYPE DIFFUSE GLIOMAS', Neuro-Oncology, 26, pp. viii57 - viii57, http://dx.doi.org/10.1093/neuonc/noae165.0227

Dsouza R; Skarne N; Mulay O; Harris L; Holton E; Zaman A; Akgul S; Offenhauser C; Alexander H; Lwin Z; Jeffree R; Inglis P-L; Powell J; Nguyen Q; Boyd A; Day B, 2024, 'TARGETING EPHA3 AND EPHRIN A5: ADVANCED PRECISION THERAPY FOR GBM', NEURO-ONCOLOGY, 26, http://dx.doi.org/10.1093/neuonc/noae165.0941

Zaman A; Muskovic W; Holton E; Pandya M; Zakanovic R; Chin V; Lam E; Yeung J; Sughrue M; Teo C; Powell J, 2024, 'A BRAIN CANCER CELL ATLAS REVEALS SHARED ASTROCYTE-LIKE STEM CELL STATES DRIVE INTRATUMOURAL HETEROGENEITY AND SHAPE IMMUNE DYNAMICS IN ADULT-TYPE DIFFUSE GLIOMAS', NEURO-ONCOLOGY, 26, pp. V3 - V3, http://dx.doi.org/10.1093/neuonc/noae144.007

Dadario NB; Zaman A; Pandya M; Dlouhy BJ; Gunawardena MP; Sughrue ME; Teo C, 2022, 'Endoscopic-assisted surgical approach for butterfly glioma surgery', Journal of Neuro Oncology, 156, pp. 635 - 644, http://dx.doi.org/10.1007/s11060-022-03945-5

Noor H; Zaman A; Teo C; Sughrue ME, 2021, 'Podnl1 methylation serves as a prognostic biomarker and associates with immune cell infiltration and immune checkpoint blockade response in lower-grade glioma', International Journal of Molecular Sciences, 22, pp. 12572, http://dx.doi.org/10.3390/ijms222212572

Caixeiro NJ; Po JW; Zaman A; Sughrue ME; Teo C, 2021, 'Charlie Teo Foundation brain tumour bank', Open Journal of Bioresources, 8, pp. 1 - 8, http://dx.doi.org/10.5334/OJB.76

Ha W; Sevim-Nalkiran H; Zaman AM; Matsuda K; Khasraw M; Nowak AK; Chung L; Baxter RC; McDonald KL, 2019, 'Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)', Scientific Reports, 9, pp. 2905, http://dx.doi.org/10.1038/s41598-019-39427-4

Zaman A; Rapkins R; Nixdorf S; Teo C; McDonald K, 2016, 'TMOD-14. ESTABLISHMENT AND MOLECULAR CHARACTERIZATION OF PATIENT DERIVED CELL LINES FROM LOW GRADE GLIOMA', Neuro-Oncology, 18, pp. vi209 - vi210, http://dx.doi.org/10.1093/neuonc/now212.884

Back to profile page